Do Community Health Centers Have Contextual Effect on the Risk of Recurrence in Patient with Tuberculosis? A Multilevel Evidence from Surakarta, Central Java

Muvida Muvida, Vitri Widyaningsih, Bhisma Murti


Background: Community Health Centers play­ed an important role in tuber­culosis con­trol. Ho­w­ever, Community Health Centers’ con­tex­tual effect toward tuberculosis recurrence has not yet been discovered. The study aims to analyze socio-demography and clinical factors of first tuber­culosis episode and Community Health Centers’ contextual effect toward tuber­culosis recurrence.

Subjects and Method: It was analytic obser­vational study with case control approach. The study was conducted in the city of Sura­kar­ta, Central Java, from December 2019 up to January 2020. Sample collection toward 204 tuberculosis patients who had completed their treatment or were confirmed cured, were con­duc­ted by using simple random sampling at individual level and stratified random sampling at community health centers level. The de­pen­dent variable was tuber­culosis recurrence. The independent variables were family income, le­vel of education, BCG vaccination status, smo­­­­king history, initial bac­terio­logical test, weight gain, DM, and COPD. The data were collected through medical record and interview. The data were analyzed by using multi­level multiple logistic regression with Stata 13.

Results: In individual level, the preventive factor toward tuberculosis recurrence among other were high income (OR= 0.24; 95% CI= 0.06 up to 0.92; p= 0.037), high level of educa­tion (OR= 0.18; 95% CI= 0.04 up to 0.84; p= 0.029), BCG vaccination status (OR= 0.11; 95% CI= 0.02 up to 0.67; p= 0.017), and high weight gain (OR= 0.06; 95% CI= 0.01 up to 0.28; p< 0.001). Meanwhile, the independent predictors toward tuberculosis recurrence (OR= 7.11; 95% CI= 1.65 up to 30.64; p= 0.009) and diabetes mellitus (OR= 10.85; 95% CI= 2.13 up to 55.29; p= 0.004). In the level of Community Health Centers, high ratio between health workers/ tuberculosis patients significantly cor­related with lower tuberculosis (OR= 0.01; 95% CI< 0.01 up to 0.44; p= 0.016). Community health Centers had contextual effect toward tuberculosis re­currence with Intra-Class Cor­relation (ICC) by 38.67%.

Conclusion: Factors in individual and com­munity health centers level may affect tuber­culosis recurrence. Community Health Centers has contextual effect toward tuberculosis re­cur­rent.

Keywords: Tuberculosis recurrence, tuber­culosis, predictor, Community Health Center, multi­­level analysis


Muvida. Masters Program in Public Health, Universitas Sebelas Maret, Jl. Ir. Su­ta­­mi No. 36 A, Surakarta 57126, Central Java. Email: muvida­md@­ Mobile: +628­965­1­4­­50435.

Journal of Epidemiology and Public Health (2020), 5(1): 65-78

Full Text:



Abbott S, Christensen H, Lalor MK, Zenner D, Campbell C, Ramsay ME, Brooks pollock E (2019). Exploring the effects of BCG vaccination in patients diagnosed with tuberculosis: Observational study using the Enhanced Tuberculosis Surveillance system. Vaccine, 37 (35): 5067–5072. doi: 10.1016/j.vaccine.2019.-06.056.

Alipanah N, Jarlsberg L, Miller C, Linh NN, Falzon D, Jaramillo E, Nahid P (2018). Adherence interventions and outcomes of tuberculosis treatment: A systematic review and meta-analysis of trials and observational studies. PLoS ONE, 15 (7): e1002595. doi: 10.1371/journal.pmed.1002595.

Balgis, Panji FH, Hifli L (2016). The relationship between HIV incidence rate, district/municipality health budget, healthy house rate, and tuberculosis prevalence in Indonesia. J Epidemiol Public Health, 1 (3): 164–174. doi: 10.26911/jepublichealth.2016.01.03.03.

Chen B, Gu H, Wang X, Wang F, Peng Y, Ge E, Upshur R et al. (2019). Prevalence and determinants of latent tuberculosis infection among frontline tuberculosis healthcare workers in southeastern China: A multilevel analysis by individuals and health facilities. Int J Infect Dis, 79: 26–33. doi: 10.1016/j.ijid.2018.11.010.

Davies GR, Wallis RS (2016). Methods for selecting regimen duration to prevent relapse in drug susceptible and drug resistant TB. Int J Tuberc Lung Dis, 20(12): S13-S17. doi: 10.5588/ijtld.16.0231.

Griffiths P, Ball J, Drennan J, Dall’Ora C, Jones J, Maruotti A, Pope C, et al (2016). Nurse staffing and patient outcomes: Strengths and limitations of the evidence to inform policy and practice. A review and discussion paper based on evidence reviewed for the National Institute for Health and Care Excellence Safe Staffing guideline development. Int J Nurs Stud. doi: 10.1016/j.ijnurstu.2016.03.012.

Hox JJ (2010). Multilevel analysis: Techniques and applications. New York: Routledge.

Hung C, Chien J, Ou C (2015). Associated factors for tuberculosis recurrence in Taiwan: A nationwide nested casecontrol study from 1998 to 2010. PloS ONE, 10(5): e0124822. doi: 10.1371/journal.pone.0124822.

Jee SH, Golub JE, Jo J, Park IS, Ohrr H, Samet JM (2009). Original contribution smoking and risk of tuberculosis incidence, mortality, and recurrence in South Korean men and women. Am J Epidemiol, 170(12): 1478–1485. doi: 10.1093/aje/kwp308

Jørgensen ME, Faurholt Jepsen D (2014). Is there an effect of glucose lowering treatment on incidence and prognosis of tuberculosis ? A systematic review. Curr Diab Rep, 14: 505. doi: 10.1007/s11892014-0505-1.

Ministry of Health (2011). Pedoman nasional pengendalian tuberkulosis. Jakarta: Kementerian Kesehatan RI.

Kim L, Moonan PK, Heilig CM, Woodruff RSY, Kammerer JS, Haddad MB (2016). Factors associated with recurrent tuberculosis more than 12 months after treatment completion. Int J Tuberc Lung Dis, 20 (1): 49–56. doi: 10.5588/ijtld.15.0442.

Lee P, Lin H, Huang AS, Wei S, Lai M, Lin H (2014). Diabetes and risk of tuberculosis relapse: nationwide nested case-control study. PLoS ONE, 9 (3): e92623. doi: 10.1371/journal.pone.0092623.

Luzze H, Johnson DF, Dickman K, Mayanja-Kizza H, Okwera A, Eisenach K, Cave MD, et al. (2013). Relapse more common than reinfection in recurrent tuberculosis 1-2 years post treatment in urban Uganda. Int J Tuberc Lung Dis, 17 (3): 361-367. doi: 10.5588/ijtld.11.0692.

Maghradze N, Jugheli L, Borrell S, Tukvadze N (2019). Classifying recurrent Mycobacterium tuberculosis cases in Georgia using MIRU VNTR typing. PLoS ONE, 14 (10): e0223610. doi: 10.1371/journal.pone.0223610.

Moosazadeh M, Bahrampour A, Nasehi M, Khanjani N (2015). The incidence of recurrence of tuberculosis and its related factors in smear positive pulmonary tuberculosis patients in Iran: A retrospective cohort study. Lung India, 32 (6): 557–560. doi: 10.4103/0970-2113.168113.

Murti B (2018). Prinsip dan metode riset epidemiologi. Surakarta: Program Studi Ilmu Kesehatan Masyarakat Universitas Sebelas Maret.

Peetluk LS, Rebeiro PF, Cordeiro-Santos M, Kritski A, Andrade BB, Durovni B, Calvaca S, et al. (2019). Lack of weight gain during the first 2 months of treatment and human immunodeficiency virus independently predict unsuccessful treatment outcomes in tuberculosis. J Infect Dis. doi: 10.1093/infdis/jiz595.

Perhimpunan Dokter Paru Indonesia (2011). Tuberkulosis: Pedoman Diagnosis dan Penatalaksanaan di Indonesia. Jakarta: Indah Offset Citra Grafika.

Restrepo BI, Schlesinger LS (2014). Impact of diabetes on the natural history of tuberculosis. Diabetes Res Clin Pract, 106 (2): 191–199. doi: 10.1016/j.diabres.2014.06.011.

Sotgiu G, Centis R, Migliori GB (2016). Tuberculosis management and determinants of recurrence. IJTLD, 20 (1): 3. doi: 10.5588/ijtld.15.090.

Sulis G, Roggi A, Matteelli A, Raviglione MC (2014). Tuberculosis: epidemiology and control. Mediterr J Hematol Infect Dis, 6(1): e2014070. doi: 10.4084/MJHID.2014.070.

Sun Y, Harley D, Vally H, Sleigh A (2017). Impact of multidrug resistance on tuberculosis recurrence and long term outcome in China. PLoS ONE, 12 (1): e0168865. doi: 10.1371/journal.pone.0168865.

van der Heijden YF, Karim F, Chinappa T, Mufamadi G, Zako L, Shepherd BE, Maruri F, et al (2018). Older age at first tuberculosis diagnosis is associated with tuberculosis recurrence in HIVnegative persons. Int J Tuberc Lung Dis, 22 (8): 871–877. doi: 10.5588/ijtld.17.0766.Older.

Velayutham B, Chadha VK, Singla N, Narang P, Rao VG, Nair S, Ramalingam S (2018). Recurrence of tuberculosis among newly diagnosed sputum positive pulmonary tuberculosis patients treated under the Revised National Tuberculosis Control Programme, India : A multi centric prospective study. PLoS ONE, 13 (7): 150-200. doi: 10.1371/journal. pone.0200150.

Vieira AA, Leite DT, Adreoni S (2017). Tuberculosis recurrence in a priority city in the state of São Paulo, Brazil. J Bras Pneumol, 43(2): 106–112. doi: 10.1590/S1806-37562016000000002.

Viswanathan V, Vigneswari A, Selvan K, Satyavani K, Rajeswari R, Kapur A (2014). Effect of diabetes on treatment outcome of smear positive pulmonary tuberculosis: A report from South India. J Diabetes Complicat, 28(2): 162–165. doi: 10.1016/j.jdiacomp.2013.12.003.

Whitehouse E, Lai J, Golub JE, Farley JE (2018). A systematic review of the effectiveness of smoking cessation interventions among patients with tuberculosis. Public Health Action, 8(2): 37-49. doi: 10.5588/pha.18.0006.

WHO (2013). Guideline: Nutritional care and support for patients with tuberculosis. Geneva: World Health Organization.

WHO (2018a). Tuberculosis. Retrieved from

WHO (2018b). Global Tuberculosis Report. Geneva: World Health Organization.

WHO (2019). Ten threats to global health in 2019.

Zellweger J, Cattamanchi A, Sotgiu G (2015). Tobacco and tuberculosis: could we improve tuberculosis outcomes by helping patients to stop smoking? Eur Respir J, 45: 583–585. doi: 10.1183/09031936.00221814.


  • There are currently no refbacks.